Thrivent Financial For Lutherans Sarepta Therapeutics, Inc. Transaction History
Thrivent Financial For Lutherans
- $28.6 Billion
- Q1 2025
A detailed history of Thrivent Financial For Lutherans transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 332,919 shares of SRPT stock, worth $11.7 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
332,919
Previous 639,332
47.93%
Holding current value
$11.7 Million
Previous $77.7 Million
54.28%
% of portfolio
0.12%
Previous 0.15%
Shares
25 transactions
Others Institutions Holding SRPT
# of Institutions
504Shares Held
88.4MCall Options Held
1.32MPut Options Held
1.06M-
Black Rock Inc. New York, NY10.3MShares$364 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$320 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$319 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$143 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$119 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.09B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...